The present invention relates to antimicrobial formulations. More particularly, the invention relates to monovalent copper-containing and/or monovalent copper-generating products for healing wounds and burns, and particularly for chronic wounds, prevention of wound infections and infections in various implants as well as medical/surgical devices.

The invention relates to an aerosol device comprising:—a container containing:—one or more propellants, and—a composition comprising one or more sebum-absorbing powders with a sebum up-take of greater than or equal to 35 ml/100 g, it being possible for the propellant(s) to be present in the composition or, in the container, separate from the composition,—a means for dispensing said composition comprising:—a body (3) that is open at its two opposite axial ends,—an engaging part (10) that is open at its two opposite axial ends, at least partially defining a dispensing orifice (12).

The invention relates to an aerosol device comprising:—a container containing:—one or more propellants, and—a composition comprising one or more sebum-absorbing powders with a sebum up-take of greater than or equal to 35 ml/100 g, it being possible for the propellant(s) to be present in the composition or, in the container, separate from the composition,—a means for dispensing said composition comprising:—a body (3) that is open at its two opposite axial ends,—an engaging part (10) that is open at its two opposite axial ends, at least partially defining a dispensing orifice (12).

An apparatus and method for depositing a particulate containing composition onto mammalian skin such that when the particles contact the mammalian skin they have a momentum defined by ρvr, which is within the range of about 0.1 kg/ms≦ρvr≦about 12.0 kg/ms. The particles can be in the range of from about 10 nanometers to about 10 micrometers, in size. And the particles may be selected from the group consisting of titanium dioxide, zinc oxide, iron oxide, polyethylene, polypropylene, polyethylene terephthalate, polycarbonate, polyvinyl chloride, glass, silica and mixtures thereof. The particles are imbedded below the first layer of dead skin cells in the stratum corneum but they do not pass all the way through the stratum corneum into the living cells of the epidermis or dermis layers of the skin.

An apparatus and method for depositing a particulate containing composition onto mammalian skin such that when the particles contact the mammalian skin they have a momentum defined by ρvr, which is within the range of about 0.1 kg/ms≦ρvr≦about 12.0 kg/ms. The particles can be in the range of from about 10 nanometers to about 10 micrometers, in size. And the particles may be selected from the group consisting of titanium dioxide, zinc oxide, iron oxide, polyethylene, polypropylene, polyethylene terephthalate, polycarbonate, polyvinyl chloride, glass, silica and mixtures thereof. The particles are imbedded below the first layer of dead skin cells in the stratum corneum but they do not pass all the way through the stratum corneum into the living cells of the epidermis or dermis layers of the skin.

Disclosed are a pharmaceutical composition, cosmetic product, and food or drink product each comprising a porous ceramic obtained by combustion synthesis of a starting material comprising (1) titanium and (2) at least one member selected from the group consisting of carbon, boron, nitrogen, and silicon; a pharmaceutical composition and cosmetic product each comprising a radical- and nanobubble-containing liquid; and a blood treatment device comprising a blood flow channel for extracorporeal circulation of a patient's blood, the blood flow channel being provided with the porous ceramic above, and the porous ceramic and the blood are brought into contact with each other.

Disclosed are a pharmaceutical composition, cosmetic product, and food or drink product each comprising a porous ceramic obtained by combustion synthesis of a starting material comprising (1) titanium and (2) at least one member selected from the group consisting of carbon, boron, nitrogen, and silicon; a pharmaceutical composition and cosmetic product each comprising a radical- and nanobubble-containing liquid; and a blood treatment device comprising a blood flow channel for extracorporeal circulation of a patient's blood, the blood flow channel being provided with the porous ceramic above, and the porous ceramic and the blood are brought into contact with each other.

Provided is a makeup cosmetic having bright fluorescent colouring whilst still having excellent transparency (being clear), and a cosmetic colouring material that is suitable for the cosmetic. The makeup cosmetic comprises (A) at least one kind of oil-soluble dye selected from the group consisting of red no. 218, red no. 223 and orange no. 201, (B) particles of a specific material selected from hydroxyapatite, calcium carbonate, a metal oxide (other than ferric oxide) and silica, and (C) oil, wherein the blending amount of pigment is not greater than 0.5 mass %, and the blending amount of water is less than 1.5 mass %. The makeup cosmetic, achieves high luminance fluorescent colouring whilst also having excellent transparency, and can be used as a lip cosmetic, blusher or eye shadow.

Dry mixtures and liquid formulations are provided that comprise metal oxide and/or metal hydroxide nanocrystalline particles. The dry mixtures are advantageously formulated with select surfactants to be readily solubilized and stable in liquid carriers. Additional select components are provided in preferred combinations that are capable of achieving improved biocidal and chemical agent efficacy. Notably, the inventive formulations provided herein allow for easier delivery of the formulations and increased shelf stability.

Dry mixtures and liquid formulations are provided that comprise metal oxide and/or metal hydroxide nanocrystalline particles. The dry mixtures are advantageously formulated with select surfactants to be readily solubilized and stable in liquid carriers. Additional select components are provided in preferred combinations that are capable of achieving improved biocidal and chemical agent efficacy. Notably, the inventive formulations provided herein allow for easier delivery of the formulations and increased shelf stability.